Compound Detail
CHEMBL1201165
QUINESTROL 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC5CCCC5)ccc4[C@H]3CC[C@@]21C
Basic Information
| ChEMBL ID | CHEMBL1201165 |
| Name | QUINESTROL |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | PWZUUYSISTUNDW-VAFBSOEGSA-N |
| Therapeutic | ✓ Yes |
4
Targets
8
Activities
2
Assay Types
0
PK Parameters
20
Publications
5
Known Names
1
Mechanisms
Molecular Properties
364.5
MW (Da)
5.23
ALogP
2
HBA
1
HBD
29.5
PSA (Ų)
0.73
QED
1
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1982 |
| Availability | Discontinued |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Estrogen receptor agonist | AGONIST | Estrogen receptor | ✓ | ✓ |
Activity Summary
EC50 4 meas. best 5.71
IC50 4 meas. best 5.22
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Streptococcus sp. 'group A' CHEMBL612389 | EC50 | 5.71 | 5.71 | 1941.0 | 1 |
| Streptokinase A CHEMBL1293228 | EC50 | 5.58 | 5.58 | 2605.0 | 1 |
| Streptococcus CHEMBL612313 | EC50 | 5.38 | 5.38 | 4175.0 | 1 |
| Unchecked CHEMBL612545 | EC50 | 5.35 | 5.35 | 4431.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 5.22 | 4.715 | 6000.0 | 4 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 20014752 | 10.1021/tx900326k | Hepatotoxicity | 3 |
| 536998 | 10.1021/jm00198a021 | Rattus norvegicus | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Mu-type opioid receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2B | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 1A | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2A | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 845869 | 10.1021/jm00213a010 | Rattus norvegicus | 2 |
| 536998 | 10.1021/jm00198a021 | Unchecked | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Glutamate receptor ionotropic, NMDA 1 | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Beta-1 adrenergic receptor | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Beta-2 adrenergic receptor | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Sodium-dependent dopamine transporter | 1 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 1 |
| - | 10.1101/2020.04.21.054387 | SARS-CoV-2 | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2C | 1 |
Data from ChEMBL 36 via Core Engine